Oramed Pharmaceuticals Inc. (ORMP) SEC Filings — 2024

Filings

• Oramed Pharmaceuticals Files 8-K Report — 8-K · Dec 17, 2024
• Oramed Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Oramed Pharmaceuticals Acquires Private Company for $10M — 8-K · Oct 29, 2024
• Oramed Pharmaceuticals Completes Merger with Premal Holdings — 8-K · Oct 8, 2024
• Oramed Pharmaceuticals Inc. Files 8-K for Material Agreement — 8-K · Sep 26, 2024
• Oramed Pharmaceuticals Files 8-K — 8-K · Sep 23, 2024
• Oramed Pharmaceuticals Inc. SC 13G Filing — SC 13G · Sep 16, 2024
• Oramed Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
• Oramed Pharmaceuticals Holds Shareholder Vote — 8-K · Aug 2, 2024
• Oramed Pharmaceuticals to Acquire N.R. Labs Ltd. — 8-K · Jun 26, 2024
• Oramed to Acquire InterCure for $137M — 8-K · Jun 24, 2024
• Oramed Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Jun 20, 2024
• Oramed Pharmaceuticals Board Changes Announced — 8-K · Jun 10, 2024
• Oramed Pharmaceuticals Announces Executive and Board Changes — 8-K · May 13, 2024
• Oramed Pharmaceuticals Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 9, 2024
• Oramed Acquires Noria Therapeutics to Expand Oral Drug Pipeline — 8-K · May 6, 2024
• Oramed CEO Nadav Kidron Files 13D — SC 13D · Mar 22, 2024
• Oramed Pharmaceuticals Files 8-K: Other Event — 8-K · Mar 19, 2024
• Oramed Pharmaceuticals Terminates Material Agreement — 8-K · Mar 18, 2024
• Oramed Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 6, 2024
• Oramed Pharmaceuticals Files 8-K for 'Other Event' and Exhibits — 8-K · Feb 20, 2024
• ORAMED PHARMACEUTICALS ENTERS MATERIAL DEFINITIVE AGREEMENT — 8-K · Jan 23, 2024
• ORAMED PHARMACEUTICALS: Leadership/Comp Changes Reported in 8-K — 8-K · Jan 19, 2024